LBT Innovations Limited (LBT.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 1.74 Million AUD | 130.25% |
| 2023 | 757 Thousand AUD | -49.5% |
| 2022 | 1.49 Million AUD | -24.48% |
| 2021 | 1.98 Million AUD | -32.46% |
| 2020 | 2.93 Million AUD | 31.85% |
| 2019 | 2.22 Million AUD | 0.0% |
| 2018 | - AUD | 100.0% |
| 2017 | -1.48 Million AUD | 0.0% |
| 2016 | - AUD | 100.0% |
| 2015 | -1.76 Million AUD | 7.41% |
| 2014 | -1.9 Million AUD | 6.9% |
| 2013 | -2.04 Million AUD | 6.46% |
| 2012 | -2.18 Million AUD | 10.09% |
| 2011 | -2.42 Million AUD | 1.22% |
| 2010 | -2.45 Million AUD | 1.48% |
| 2009 | -2.49 Million AUD | 0.28% |
| 2008 | -2.5 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 1.74 Million AUD | 130.25% |
| 2024 Q4 | 1.74 Million AUD | 0.0% |
| 2024 Q2 | 1.74 Million AUD | 0.0% |
| 2023 Q2 | 1 Million AUD | 0.0% |
| 2023 FY | 757 Thousand AUD | -49.5% |
| 2023 Q4 | 757 Thousand AUD | 0.0% |
| 2022 Q4 | 1.49 Million AUD | 0.0% |
| 2022 FY | 1.49 Million AUD | -24.48% |
| 2022 Q2 | 1.98 Million AUD | 0.0% |
| 2021 Q4 | 1.98 Million AUD | 0.0% |
| 2021 FY | 1.98 Million AUD | -32.46% |
| 2021 Q2 | 2.46 Million AUD | 0.0% |
| 2020 Q4 | 2.93 Million AUD | 0.0% |
| 2020 FY | 2.93 Million AUD | 31.85% |
| 2020 Q2 | 1.41 Million AUD | 0.0% |
| 2019 FY | 2.22 Million AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | 2.22 Million AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 100.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | -1.48 Million AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 Q4 | -1.62 Million AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 100.0% |
| 2015 Q4 | -1.76 Million AUD | 0.0% |
| 2015 FY | -1.76 Million AUD | 7.41% |
| 2015 Q2 | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 FY | -1.9 Million AUD | 6.9% |
| 2014 Q4 | -1.9 Million AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | -2.04 Million AUD | 0.0% |
| 2013 FY | -2.04 Million AUD | 6.46% |
| 2012 FY | -2.18 Million AUD | 10.09% |
| 2012 Q4 | -2.18 Million AUD | 0.0% |
| 2011 FY | -2.42 Million AUD | 1.22% |
| 2011 Q4 | -2.42 Million AUD | 0.0% |
| 2010 Q4 | -2.45 Million AUD | 0.0% |
| 2010 FY | -2.45 Million AUD | 1.48% |
| 2009 FY | -2.49 Million AUD | 0.28% |
| 2009 Q4 | -2.49 Million AUD | 0.0% |
| 2008 FY | -2.5 Million AUD | 0.0% |
| 2008 Q4 | -2.5 Million AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 58.262% |
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 70.455% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | -13.979% |
| Control Bionics Limited | 336.16 Thousand AUD | -418.495% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 99.138% |
| CleanSpace Holdings Limited | 2.76 Million AUD | 36.997% |
| Cyclopharm Limited | 4.01 Million AUD | 56.564% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | 1.327% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 85.986% |
| ImpediMed Limited | 810 Thousand AUD | -115.185% |
| InhaleRx Limited | - AUD | -Infinity% |
| Micro-X Limited | 65 Thousand AUD | -2581.538% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | -134.906% |
| Respiri Limited | - AUD | -Infinity% |
| SomnoMed Limited | 709.07 Thousand AUD | -145.814% |
| Universal Biosensors, Inc. | 3.22 Million AUD | 45.965% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |